Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

ACRX

AcelRX Pharmaceuticals (ACRX)

AcelRX Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ACRX
DateTimeSourceHeadlineSymbolCompany
12/23/20157:00AMPR Newswire (US)AcelRx Pharmaceuticals Receives Notice of Eligibility for Centralized Review of ARX-04 from European Medicines AgencyNASDAQ:ACRXAcelRX Pharmaceuticals Inc
12/14/20157:02AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
12/14/20157:00AMPR Newswire (US)AcelRx Pharmaceuticals Conducts Pre-NDA Meeting with U.S. Food and Drug Administration for ARX-04NASDAQ:ACRXAcelRX Pharmaceuticals Inc
12/08/20159:11AMEdgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
11/23/20157:00AMPR Newswire (US)AcelRx Pharmaceuticals to Present at Piper Jaffray 27th Annual Healthcare ConferenceNASDAQ:ACRXAcelRX Pharmaceuticals Inc
11/19/20154:16PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
11/19/20157:00AMPR Newswire (US)AcelRx Pharmaceuticals Announces Sublingual Sufentanil Data Presentation at the American Society of Regional Anesthesia and P...NASDAQ:ACRXAcelRX Pharmaceuticals Inc
11/13/20153:12PMEdgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
11/10/20157:00AMPR Newswire (US)AcelRx Pharmaceuticals to Present at Jefferies 2015 Global Healthcare ConferenceNASDAQ:ACRXAcelRX Pharmaceuticals Inc
11/05/20157:00AMPR Newswire (US)AcelRx Pharmaceuticals to Present at Credit Suisse 24th Annual Healthcare ConferenceNASDAQ:ACRXAcelRX Pharmaceuticals Inc
11/04/20157:00AMPR Newswire (US)AcelRx Pharmaceuticals Presents Data from Phase 3 Clinical Trials Evaluating the Safety and Efficacy of Zalviso in Obese Surg...NASDAQ:ACRXAcelRX Pharmaceuticals Inc
10/29/20154:10PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
10/29/20154:01PMPR Newswire (US)AcelRx Pharmaceuticals Provides Business Update and Reports Third Quarter and Nine Months 2015 Financial ResultsNASDAQ:ACRXAcelRX Pharmaceuticals Inc
10/26/20157:00AMPR Newswire (US)AcelRx Pharmaceuticals to Hold Business Update and Third Quarter Financial Results Conference Call and Webcast on Thursday, O...NASDAQ:ACRXAcelRX Pharmaceuticals Inc
10/23/20157:00AMPR Newswire (US)AcelRx Pharmaceuticals Announces Presentation Of Phase 3 Data From ARX-04 Sufentanil Sublingual 30 mcg Program At The America...NASDAQ:ACRXAcelRX Pharmaceuticals Inc
10/09/20157:00AMPR Newswire (US)AcelRX Pharmaceuticals Announces Presentation Of Phase 3 Sufentanil Sublingual 30mcg Tablet Data At The European Society Of E...NASDAQ:ACRXAcelRX Pharmaceuticals Inc
10/08/20157:01AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
10/08/20157:00AMPR Newswire (US)AcelRx Pharmaceuticals Provides Regulatory Update on ZalvisoNASDAQ:ACRXAcelRX Pharmaceuticals Inc
10/06/20157:00AMPR Newswire (US)AcelRx Pharmaceuticals Announces Initiation of Clinical Study with ARX-04 in Emergency Room Patients with Moderate-to-Severe ...NASDAQ:ACRXAcelRX Pharmaceuticals Inc
10/01/20157:00AMPR Newswire (US)AcelRx Pharmaceuticals Appoints Gina Ford as Vice President Commercial StrategyNASDAQ:ACRXAcelRX Pharmaceuticals Inc
09/24/20157:00AMPR Newswire (US)AcelRx Pharmaceuticals to Host Analyst & Investor Event on October 2, 2015NASDAQ:ACRXAcelRX Pharmaceuticals Inc
09/22/20152:57PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
09/22/20158:41AMPR Newswire (US)AcelRx Pharmaceuticals Reports that the European Commission has Granted Marketing Authorization for Zalvisoâ„¢ for Treatment ...NASDAQ:ACRXAcelRX Pharmaceuticals Inc
09/21/20157:00AMPR Newswire (US)PDL BioPharma Acquires a Portion of AcelRx Pharmaceuticals' Expected Royalties and Commercial Milestones from Zalvisoâ„¢ for ...NASDAQ:ACRXAcelRX Pharmaceuticals Inc
09/21/20157:00AMPR Newswire (US)AcelRx Pharmaceuticals Receives $65 Million from the Partial Sale of Zalvisoâ„¢ European Royalties and Commercial Milestones ...NASDAQ:ACRXAcelRX Pharmaceuticals Inc
09/21/20156:20AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
09/11/20154:03PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
09/09/20157:00AMPR Newswire (US)AcelRx Pharmaceuticals' ARX-04 Meets all Endpoints in Pivotal Phase 3 Study for Moderate-to-Severe Acute PainNASDAQ:ACRXAcelRX Pharmaceuticals Inc
09/09/20156:07AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
09/08/20156:05AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:ACRX